secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001437749-23-027180
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen stockholders re-elect directors, approve equity plan increase to 1M shares
--------------------------------------------------------------------------------

- Seven director nominees re-elected; votes for ranged from 1.44M to 1.67M, withholds 416k to 642k.
- Advisory say-on-pay approved with 1.38M for, 607k against, 96k abstain.
- Amendment to 2019 Omnibus Equity Incentive Plan approved: authorized shares increased from 600k to 1M.
- Ratification of WithumSmith+Brown as auditors for FY ending March 31, 2024 approved (3.93M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774923027180/0001437749-23-027180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774923027180/vtgn20230921_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer